Physician profile
Priscilla K Willander
NPI 1629245766
$1,065.70
in general payments reported to CMS, 2019-2025
22 companies · $90.31 in 2025
The $90.31 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $284 · 2022: $131 · 2023: $198 · 2024: $364 · 2025: $90.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $651.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $261.71 | 2021-2024 | Zeposia |
| Abbvie INC. | $154.59 | 2021-2025 | |
| Janssen Biotech, INC. | $124.44 | 2021-2023 | Remicade, Stelara, Simponi Aria |
| Merck Sharp & Dohme LLC | $68.88 | 2022-2024 | Dificid |
| Daiichi Sankyo INC. | $48.14 | 2022-2024 | Injectafer |
| Boston Scientific Corporation | $45.22 | 2025 | Axonics |
| Medtronic, INC. | $42.17 | 2021-2022 | |
| Amgen INC. | $33.82 | 2023 | Avsola, Amjevita |
| Blueprint Medicines Corporation | $29.02 | 2023 | |
| Ipsen Biopharmaceuticals, INC | $27.92 | 2023-2024 | Bylvay |
| Mauna Kea Technologies, INC. | $24.73 | 2024 | |
| Phathom Pharmaceuticals, INC. | $24.30 | 2023-2025 | Voquezna |
| Enterra Medical, INC. | $21.77 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.97 | 2023 | Cyltezo |
| Qol Medical, LLC | $20.55 | 2023 | Sucraid |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $19.45 | 2022 | |
| Axonics, INC. | $19.17 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $19.01 | 2024 | Dupixent |
| Gilead Sciences, INC. | $16.78 | 2021 | |
| Nestle Healthcare Nutrition INC. | $15.27 | 2021 | |
| Pfizer INC. | $14.03 | 2021 | |
| Aimmune Therapeutics, INC. | $13.76 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priscilla Willander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.